Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ June 10, 2023 ] Graduating senior lights the path for transfer students – through her award-winning research and mentoring Los Angeles Biotech News
  • [ June 10, 2023 ] Postdoctoral Scientist – Karsh Division of Gastroenterology and Hepatology – Part-Time – CEDARS-SINAI – Los Angeles, CA Los Angeles Biotech Jobs
  • [ June 10, 2023 ] Adcomm votes yes on Leqembi full OK; Merck brings first IRA lawsuit; Special: LGBTQ+ leaders; Best-paying biopharma jobs; and more Los Angeles Biotech News
  • [ June 10, 2023 ] Scientist, Cell Biology – Thermo Fisher Scientific – West Hills, CA Los Angeles Biotech Jobs
  • [ June 10, 2023 ] Security Officer – Biotechnology Company – Allied Universal® – Oceanside, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsLightship, Inc. Market Research Confirms Patients’ Interest in Direct-to-Patient Trial Offering Amidst COVID-19 Pandemic

Lightship, Inc. Market Research Confirms Patients’ Interest in Direct-to-Patient Trial Offering Amidst COVID-19 Pandemic

May 29, 2020 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Lightship, Inc. Market Research Confirms Patients’ Interest in Direct-to-Patient Trial Offering Amidst COVID-19 Pandemic
LOS ANGELES--(BUSINESS WIRE)--Clinical research market ripe for remote trial offering

Click to view original post

Previous

Annenberg Foundation and Two Bit Circus Foundation Ignite Lifelong Love for Arts and Sciences with Free STEAM-Based Online Projects

Next

Sierra Oncology brings on former Aimmune CEO to the helm; Flagship woos ex-Novartis exec Fabrice Chouraqui

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered